Valuation: Sanofi

Market Cap 104B 115B 95.87B 86.66B 164B 10,798B 168B 1,149B 458B 5,783B 432B 423B 18,403B P/E 2026 *
13.6x
P/E 2027 * 11.5x
Enterprise Value 115B 128B 107B 96.39B 182B 12,010B 187B 1,278B 509B 6,432B 481B 470B 20,468B EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.17x
Free-Float
88.8%
Yield 2026 *
4.92%
Yield 2027 * 5.19%
1 day+1.80%
1 week+4.31%
Current month+10.57%
1 month+23.14%
3 months+16.91%
6 months+20.19%
Current year+6.59%
1 week 81.74
Extreme 81.74
88.48
1 month 70.1
Extreme 70.1
88.48
Current year 69.75
Extreme 69.75
88.48
1 year 69.75
Extreme 69.75
90.79
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer - 01/09/2026
Director TitleAgeSince
Director/Board Member 61 30/04/2019
Director/Board Member 56 28/04/2020
Director/Board Member 65 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
14/10/26 Sell

Executive/Senior Manager

-647 0.0001%
20/8/26 Buy

Chief Executive Officer

1,506 0.0001%
20/8/26 Buy

Head of Human Resources

54 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+1.79%+4.31%-2.17%+3.38% 115B
+0.35%+1.36%+45.38%+140.47% 1,280B
-0.13%+1.48%+44.67%+90.43% 675B
+0.37%+0.05%+31.00%+112.84% 521B
+1.01%+3.73%+39.91%+70.18% 386B
-0.59%-2.11%+61.83%+45.16% 363B
+1.36%+0.37%+28.58%+59.09% 301B
+1.09%+0.09%+3.97%+37.15% 286B
+0.62%-2.17%+38.31%+75.12% 253B
-0.67%-2.72%+38.49%+123.56% 211B
Average +0.88%-0.16%+33.00%+75.74% 439B
Weighted average by Cap. +1.24%+0.27%+38.61%+94.96%

Financials

2026 *2027 *
Net sales 48.91B 54.27B 45.19B 40.85B 77.29B 5,090B 79.2B 542B 216B 2,726B 204B 199B 8,675B 51.53B 57.17B 47.61B 43.04B 81.43B 5,362B 83.44B 571B 227B 2,872B 215B 210B 9,140B
Net income 7.68B 8.52B 7.09B 6.41B 12.13B 799B 12.43B 84.99B 33.88B 428B 31.96B 31.28B 1,361B 9.24B 10.25B 8.53B 7.72B 14.6B 961B 14.96B 102B 40.77B 515B 38.47B 37.65B 1,638B
Net Debt 11.64B 12.92B 10.76B 9.72B 18.4B 1,212B 18.85B 129B 51.38B 649B 48.48B 47.45B 2,065B 7.92B 8.79B 7.32B 6.62B 12.52B 824B 12.83B 87.7B 34.96B 441B 32.98B 32.28B 1,405B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
12/11/26 €88.16 +1.79% 558,058
11/11/26 €86.61 +0.77% 2,855,036
10/11/26 €85.95 +0.22% 3,213,951
09/11/26 €85.76 +2.41% 2,881,635
06/11/26 €83.74 -0.93% 3,228,987
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
86.61EUR
Average target price
95.70EUR
Spread / Average Target
+10.50%